Skip to content
Pharma Observatory a Scientist.com platform

Organization (Hospital)

St. Luke's-Roosevelt Hospital Center

ClinicalTrials.gov lists St. Luke's-Roosevelt Hospital Center as lead sponsor of 69 trials. It has 23 approved assets.

US Hospital
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

12 0 1996 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Logo Mount Sinai Health System, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.

This page covers St. Luke's-Roosevelt Hospital Center: 69 lead-sponsored trials and 1 legal-entity registration.

Get the St. Luke's-Roosevelt Hospital Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (97)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Obesity 18
Pain 8
Substance-Related Disorders 6
Colorectal Neoplasms 5
HIV Infections 5

Showing 5 of 97 disease areas.

Start your 14-day trial Email me the first 50 disease areas as a PDF

Trials by start year as sponsor or collaborator (16)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2015 4
2014 7
2013 8
2012 10
2011 10
2010 12
2009 7
2008 8
2007 8
2006 5

Showing 10 of 16 years.

Start your 14-day trial Email me all 16 years as a PDF

Recruitment duration, a model prediction: none of the 69 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Approved assets (23)

Shown in this order: max phase first.

Approved assets
Drug Trials
+/- Bupivacaine HCl 4
Ultrasound-Guided Adductor Canal Block 1
Bupivacaine HCl with Epinephrine 1
Bupivacaine %0.25 (isobaric) 1
Beta Blocker 1

Showing 5 of 23 approved assets.

Start your 14-day trial Email me all 23 approved assets as a PDF

Journals published in (110)

Shown in this order: most published in first.

Journals published in
Journal Publications
The New England journal of medicine 9
Investigative ophthalmology & visual science 7
Stroke 7
The American journal of clinical nutrition 6
Critical care medicine 5

Showing 5 of 110 journals.

Start your 14-day trial Email me the first 50 journals as a PDF

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
3 0 2018-02-06

Organization relationships (23)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
University of California System Co sponsors trial with 3
Beth Israel Medical Center Co sponsors trial with 3
Hahnemann University Hospital Co sponsors trial with 2
Patient-Centered Outcomes Research Institute Co sponsors trial with 1
New York University Co sponsors trial with 1

Showing 5 of 23 relationships.

Start your 14-day trial Email me all 23 relationships as a PDF

Latest dated events (98)

Shown in this order: newest first.

Latest dated events
Date Event Source
2018-02-06 Patent granted Granted US patents (PatentsView / USPTO)
2015-12 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2015-09 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2015-06-30 Patent granted Granted US patents (PatentsView / USPTO)
2015-05 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 98 events.

Start your 14-day trial Email me the first 50 events as a PDF

Biomarker capability evidence (41)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
ALB Trial sponsor Named in trial inclusion criteria
AMH Trial sponsor Named in trial inclusion criteria
ART4 Trial collaborator Named in trial inclusion criteria
CD4 Trial collaborator Named in trial inclusion criteria
CD4 Trial collaborator Named in trial inclusion criteria

Showing 5 of 41 evidence rows.

Start your 14-day trial Email me all 41 evidence rows as a PDF

Biomarkers this organization publishes on (59)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
INS 14
GCG 8
GIP 6
LEP 5
ALB 4

Showing 5 of 59 biomarkers.

Start your 14-day trial Email me the first 50 biomarkers as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.